Polymarket
Lead Bank in Anthropic's IPO?
Morgan Stanley
GS · NYSE
buy · 13 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| July 17, 2026 | BMO Capital | Maintains | Market Perform | $1,150.00 |
| July 17, 2026 | Evercore ISI Group | Maintains | Outperform | $1,210.00 |
| July 16, 2026 | Citigroup | Maintains | Neutral | $1,200.00 |
| July 16, 2026 | B of A Securities | Maintains | Buy | $1,300.00 |
| July 15, 2026 | BMO Capital | Maintains | Market Perform | $1,190.00 |
| July 15, 2026 | JP Morgan | Maintains | Neutral | $955.00 |
| July 15, 2026 | Barclays | Maintains | Overweight | $1,245.00 |
| July 15, 2026 | Keefe, Bruyette & Woods | Maintains | Market Perform | $1,130.00 |
| July 15, 2026 | Wells Fargo | Maintains | Overweight | $1,325.00 |
| July 7, 2026 | B of A Securities | Maintains | Buy | $1,150.00 |
| July 7, 2026 | UBS | Maintains | Neutral | $1,120.00 |
| July 6, 2026 | Evercore ISI Group | Maintains | Outperform | $1,075.00 |
| June 29, 2026 | Morgan Stanley | Maintains | Equal-Weight | $1,099.00 |
| June 24, 2026 | Wells Fargo | Maintains | Overweight | $1,195.00 |
| June 23, 2026 | Citigroup | Maintains | Neutral | $1,100.00 |
| June 12, 2026 | JP Morgan | Maintains | Neutral | $900.00 |
| May 8, 2026 | Citigroup | Maintains | Neutral | $930.00 |
| April 20, 2026 | BMO Capital | Maintains | Market Perform | $972.00 |
| April 14, 2026 | Wells Fargo | Maintains | Overweight | $1,000.00 |
| April 14, 2026 | B of A Securities | Maintains | Buy | $1,050.00 |
| April 13, 2026 | UBS | Maintains | Neutral | $930.00 |
| April 7, 2026 | UBS | Maintains | Neutral | $930.00 |
| April 6, 2026 | Evercore ISI Group | Maintains | Outperform | $950.00 |
| April 6, 2026 | BMO Capital | Maintains | Market Perform | $905.00 |
| April 6, 2026 | Jefferies | Maintains | Buy | $1,049.00 |
| March 10, 2026 | JP Morgan | Maintains | Neutral | $826.00 |
| January 27, 2026 | Freedom Broker | Maintains | Hold | $940.00 |
| January 20, 2026 | BMO Capital | Maintains | Market Perform | $985.00 |
| January 20, 2026 | RBC Capital | Maintains | Sector Perform | $1,030.00 |
| January 16, 2026 | Wells Fargo | Maintains | Overweight | $1,050.00 |
| January 16, 2026 | Keefe, Bruyette & Woods | Maintains | Market Perform | $1,000.00 |
| January 8, 2026 | JP Morgan | Maintains | Neutral | $775.00 |
| January 5, 2026 | Barclays | Maintains | Overweight | $1,048.00 |
| December 17, 2025 | Keefe, Bruyette & Woods | Maintains | Market Perform | $971.00 |
| October 21, 2025 | JP Morgan | Downgrades | Neutral | $750.00 |
| October 17, 2025 | Freedom Broker | Upgrades | Hold | $794.00 |
| October 17, 2025 | Keefe, Bruyette & Woods | Maintains | Market Perform | $870.00 |
| October 16, 2025 | Citigroup | Maintains | Neutral | $765.00 |
| October 15, 2025 | Barclays | Maintains | Overweight | $850.00 |
| October 15, 2025 | Morgan Stanley | Maintains | Equal-Weight | $828.00 |
| October 7, 2025 | UBS | Maintains | Neutral | $805.00 |
| September 30, 2025 | Evercore ISI Group | Maintains | Outperform | $830.00 |
| September 29, 2025 | Morgan Stanley | Maintains | Equal-Weight | $854.00 |
| September 16, 2025 | Wells Fargo | Maintains | Overweight | $855.00 |
Live event probabilities associated with this company or market.
Polymarket
Morgan Stanley
Polymarket
Goldman Sachs
Goldman Sachs posted Q2 revenue of $20B, beating expectations by 24%, with EPS of $20.98 surpassing forecasts by 44%. Analysts at BofA raised their price target to $1,300 and Barclays to $1,245, citing a broadening M&A, IPO, and underwriting cycle that could sustain elevated investment banking fees well into 2026.
Despite strong Q2 results, JPMorgan maintains a Neutral rating with a comparatively modest price target of $955, and the broader consensus sits at just 'Hold.' Macro headwinds — including sticky inflation, a hawkish Fed path, and geopolitical tensions — could delay deal pipelines and suppress capital markets activity.
Based on 27 years of historical data, GS is forecast to reach $1,257 over the next 52 weeks, with a Financhill Stock Score of 70/100 — 40% above its historic median — suggesting lower risk than normal. Analyst consensus upgrades following Q2 results lifted the average price target by 8% to $1,090 per share.
Technical indicators on GS show bearish RSI divergence, weakening momentum, and repeated failures to reclaim the 20-day moving average after the stock hit an all-time high of $1,125 in June 2026. Analysts warn of a potential multi-week mean-reversion decline toward the $905–$1,000 support range.
Following Q2 results, 19 analysts now forecast Goldman Sachs revenues of $72B in 2026, representing 6.6% growth year-over-year and a 14% annualized growth rate — nearly 2.5 times the projected 5.8% industry average. EPS estimates were revised sharply upward from $60.44 to $70.40, reflecting a material improvement in analyst conviction.
Despite the post-earnings upgrade cycle, the analyst community remains deeply divided, with price targets spanning $730 to $1,325 per share. The consensus rating stands at 'Hold' across 25 analysts, with Citi and JPMorgan both maintaining Neutral ratings even after raising their targets, signaling skepticism about further upside at current valuations.